Long term outcomes of genome edited ‘universal’ CAR19 T-cells for relapsed/refractory B-ALL at a single pediatric centre

Blood Adv. 2025 Jul 2:bloodadvances.2025016366. doi: 10.1182/bloodadvances.2025016366. Online ahead of print.

NO ABSTRACT

PMID:40601899 | DOI:10.1182/bloodadvances.2025016366